Second Sight Medical Products, Inc. (EYES) Discounted Future Market Cap - Discounting Cash Flows
Second Sight Medical Products, Inc.
EYES (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 4.17 USD
Estimated net income -19.18 Mil. USD
Estimated market capitalization 111.8 Mil. USD
Market capitalization discounted to present 54.81 Mil. USD
Shares Outstanding 13.14 Mil.
Earnings Per Share (EPS) -0.71 USD
Market Price 4.14 USD
Price to Earnings (PE) Ratio -808.6

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue
0.26 -5.84 -5.46 -5.1 -4.77 -4.46
Revenue Growth Rate
-6.49% -6.49% -6.49% -6.49%
Net Income
-9.08 -25.09 -23.46 -21.94 -20.51 -19.18

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 3.85 0.26
-0.13 -0.5 3.38 6.9 7.96 3.98 8.95
Cost of Revenue 4.57 -0.13
0 0 2.15 4.89 5.12 10.08 5.29
Gross Profit 0.426 0.39
-0.13 -0.5 1.23 2.01 2.85 -6.09 3.66
Gross Margin 42.4% 150%
100% 100% 36.31% 29.12% 35.75% -152.8% 40.86%
Operating Income -22.98 -9.07
-8.91 -14.9 -33.95 -35.18 -28.61 -33.21 -20.05
Operating Margin 426.5% -3,488%
6,853% 2,979% -1,005% -510.2% -359.2% -833.4% -224%
Net Income -22.91 -9.08
-8.93 -14.88 -33.59 -35.09 -28.52 -33.18 -20.02
Net Margin 430% -3,491%
6,872% 2,976% -994.1% -508.9% -358.1% -832.6% -223.7%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 3.85 0.26
-0.13 -0.5 3.38 6.9 7.96 3.98 8.95
Revenue Growth Rate -6.49%
-74% -114.8% -51% -13.41% 99.85% -55.47% 163.4%
Net Income -22.91 -9.08
-8.93 -14.88 -33.59 -35.09 -28.52 -33.18 -20.02
Net Margin 430% -3,491%
6,872% 2,976% -994.1% -508.9% -358.1% -832.6% -223.7%
Net Income Growth Rate -9.76%
-39.97% -55.7% -4.28% 23.07% -14.05% 65.75% -43.13%
Stockholders Equity 22.55 63.06
68.36 -0.672 7.28 3.08 7.88 11.15 20.26
Equity Growth Rate -1,489%
-10,270% -109.2% 135.9% -60.87% -29.3% -44.98% -41.47%
Return on Invested Capital (ROIC) 600.6% -136.8%
758.6% 387.8% 2,056% 2,549% -395.7% -313.6% -100.4%
After-tax Operating Income -23.15 -9.14
-8.92 -14.93 -34.69 -35.35 -28.8 -33.27 -20.11
Income Tax Rate -0.608% -0.739%
-0.135% -0.215% -2.15% -0.49% -0.652% -0.187% -0.29%
Invested Capital 4.56 6.68
-1.18 -3.85 -1.69 -1.39 7.28 10.61 20.02
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us